Global Health Day

The OGHI hosts the Global Health Day Symposium each April during National Public Health Week. This annual event brings together experts researching global health issues, and is co-sponsored by the Community for Global Health Equity. 

11th Annual Global Health Day Symposium: Ongoing Challenges Around COVID-19

Fri., April 22, 1 to 4 p.m

Keynote speakers

Dr. Janet Diaz, MD.

Janet Diaz, MD

Team lead,
Clinical Management
WHO Health Emergencies Programme

Dr. Janet Diaz, MD, is the head of clinical care, WHO Health Emergencies Programme. Since 2018, she has worked as the lead for the Clinical Management Team that is responsible for readiness and response to emerging infectious diseases, such as COVID-19 and Ebola. Her unit is responsible for developing the COVID-19 Living guidelines on Therapeutics and Clinical Management, spearheading the oxygen access scale up initiative and advancing clinical research agenda around emerging infectious diseases.

Dr. Diaz is an accomplished specialist in pulmonary and critical care medicine with expertise in clinical medicine and global health. She is committed to working with medical and public health professionals to deliver quality, safe, and cost-efficient care to critically ill patients in resource-limited regions.

Previously, she worked at the California Pacific Medical Center, a tertiary referral center in San Francisco. She received her post-graduate training in Internal, Pulmonary and Critical Care Medicine at the University of California San Francisco (UCSF). From 2006-2010, she served as the Medical Director of the MICU at San Francisco General Hospital and as an Assistant Clinical Professor at UCSF where she was recognized for her leadership in hospital quality, patient safety and clinical teaching.

Dr. Avindra Nath.

Neurological complications of COVID-19 infection

Avindra Nath, MD

Clinical Director

National Institute of Neurological Disorders and Stroke (NINDS)
National Institutes of Health (NIH)

NINDS Translational Neuroscience Center

Dr. Nath is the clinical director of NINDS, the director of the Translational Neuroscience Center and chief of the section of infections of the nervous system, positions he has held since 2011.

Dr. Nath focuses his research on retroviral infections of the nervous system and their link to neuroinflammatory and neurodegenerative diseases, and he works to develop new ways to diagnose and treat these diseases. The illnesses he studies are varied, and include HIV, ALS and MS, as well as (re)emerging infectious diseases. Dr. Nath’s expertise is in managing patients with CNS infections or with immune disorders where an infectious etiology may be suspected. He has led several national and international efforts to study outbreaks or neurological illnesses where an infectious or immune component is suspected, such as Ebola, Zika, Nodding syndrome, HHV-6 encephalitis and SARS-CoV-2, and he serves on various WHO, CDC, NIH, FDA and HHS committees related to these topics.

Since the emergence of SARS-CoV-2, Dr. Nath has played a leadership role in categorizing and drawing attention to the neurological complications of the infection. He has organized multi-institutional efforts, workshops and seminars, given keynote addresses, and given nearly 100 interviews in all major news media about COVID-19. Dr. Nath has also testified at the Congressional Neuroscience committee and the National Academy of Medicine to draw attention to the long-term complications of the illness.

Prior to his work at the NIH, Dr. Nath held faculty positions at the University of Manitoba, the University of Kentucky, and Johns Hopkins University. He received his MD from Christian Medical College in India. 



COVID updates

Thomas A. Russo, MD
Professor and Chief, Infectious Disease

Department of Medicine
Jacobs School of Medicine and Biomedical Sciences
University at Buffalo

Yinyin Ye, PhD.

Tracking SARS-CoV-2 variants in municipal wastewater

Yinyin Ye, PhD
Assistant Professor
Environmental Engineering
Department of Civil, Structural and Environmental Engineering
School of Engineering and Applied Sciences
University at Buffalo

Meng Wang, PhD.

Clean air and COVID pandemic: an opportunity for radical change

Meng Wang, PhD
Assistant Professor
Department of Epidemiology and Environmental Health
School of Public Health and Health Professions
University at Buffalo

Dr. Lina Mu.

COVID pandemic and impacts on mental health

Lina Mu, PhD, MD
Associate Professor
Department of Epidemiology and Environmental Health
Director, Office of Global Health Initiatives
School of Public Health and Health Professions
University at Buffalo